Ishiwata, Sayaki
Kasai, Takatoshi http://orcid.org/0000-0001-5747-7668
Sato, Akihiro
Suda, Shoko
Matsumoto, Hiroki
Shitara, Jun
Yatsu, Shoichiro
Murata, Azusa
Shimizu, Megumi
Kato, Takao
Hiki, Masaru
Matsue, Yuya
Naito, Ryo
Daida, Hiroyuki
Minamino, Tohru
Funding for this research was provided by:
a Grant-in-Aid for Scientific Research (26507010)
JSPS KAKENHI (JP17K09527, JP18K15904)
Article History
Received: 17 May 2021
Accepted: 2 November 2021
First Online: 11 November 2021
Declarations
:
: Dr. S. Ishiwata, Dr. T. Kasai, Dr. A. Sato, Dr. Y. Matsue, and Dr. R. Naito are affiliated with a department endowed by Philips, ResMed, and Fukuda Denshi. Dr. T. Kasai is affiliated with an endowed department by Paramount Bed. Dr. Y. Matsue received an honorarium from Otsuka Pharmaceutical Co. and Novartis Japan, and received research funds from Otsuka Pharmaceutical Co. and Pfizer Japan Inc. Dr. H. Daida reports research grants from CANON MEDICAL SYSTEMS CORPORATION, Philips Japan, Ltd., TOHO HOLDINGS CO., LTD., ASAHI KASEI CORPORATION, Inter Reha Co., Ltd., scholarship grants from Nippon Boehringer Ingelheim Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Sanofi K.K., MSD K.K., Daiichi-Sankyo Company, Limited, Pfizer Co., Ltd., Mitsubishi Tanabe Pharma Corp., Astellas Pharma Inc., Takeda Pharmaceutical Co. Ltd., TEIJIN PHARMA LTD., Shionogi & Co. Ltd., Actelion Pharmaceuticals Ltd., Actelion Ltd., KOWA Pharmaceutical Company Ltd., Bayer Yakuhin, Ltd, lecture fees from Amgen Inc., Daiichi-Sankyo Company, Ltd., KOWA Pharmaceutical LTD., MSD K.K.
: The Institutional Review Board of the Juntendo University Hospital approved the study protocol (871).
: The study complied with the Declaration of Helsinki. Informed consent was obtained from all patients.
: Consent to publish was obtained.
: All study participants provided informed consent.